Increased muscle activity during sleep and more RBD symptoms in H1N1-(Pandemrix)-vaccinated narcolepsy type 1 patients compared with their nonnarcoleptic siblings


 
 
 Narcolepsy type 1 (NT1) is characterized by unstable sleep-wake and muscle tonus regulation during sleep. We characterized dream enactment and muscle activity during sleep in a cohort of post-H1N1 NT1 patients and their siblings, and analysed whether clinical phenotypic characteristics and major risk factors are associated with increased muscle activity.
 
 
 
 RBD symptoms and polysomnography m. tibialis anterior electromyographical signals (long (0.5–15 s); short (0.1–0.49 s)) were compared between 114 post-H1N1 NT1 patients and 89 nonnarcoleptic siblings. Association subanalyses with RBD symptoms, narcoleptic symptoms, CSF hypocretin-1 levels, and major risk factors (H1N1-(Pandemrix)-vaccination, HLA-DQB1*06:02 positivity) were performed.
 
 
 
 RBD symptoms, REM and NREM long muscle activity indices and REM short muscle activity index were significantly higher in NT1 patients than siblings (all p < 0.001). Patients with undetectable CSF hypocretin-1 levels (<40 pg/ml) had significantly more NREM periodic long muscle activity than patients with low but detectable levels (40–150 pg/ml) (p = 0.047). In siblings, REM and NREM sleep muscle activity indices were not associated with RBD symptoms, other narcolepsy symptoms, or HLA-DQB1*06:02-positivity. H1N1-(Pandemrix)-vaccination status did not predict muscle activity indices in patients or siblings.
 
 
 
 Increased REM and NREM muscle activity and more RBD symptoms is characteristic of NT1, and muscle activity severity is predicted by hypocretin deficiency severity but not by H1N1-(Pandemrix)-vaccination status. In the patients’ nonnarcoleptic siblings, neither RBD symptoms, core narcoleptic symptoms, nor the major NT1 risk factors is associated with muscle activity during sleep, hence not indicative of a phenotypic continuum.
